Successful Drug Development Despite Adverse Preclinical Findings : Part 1 : Processes to Address Issues and Most Important Findings

スポンサーリンク

概要

• 論文の詳細を見る
• 2010-12-01

著者

• Ettlin Robert

  Ettlin Consulting Ltd.

• Kuroda Junji

  KISSEI Pharmaceutical Co., Ltd.

• Plassmann Stephanie

  PreClinical Safety (PCS) Consultants Ltd.

• Prentice David

  PreClinical Safety (PCS) Consultants Ltd.

• Ettlin Robert

  Ettlin Consulting Ag

関連論文

• Successful Drug Development Despite Adverse Preclinical Findings Part 2: Examples
• Successful Drug Development Despite Adverse Preclinical Findings Part 1: Processes to Address Issues and Most Important Findings
• International Recommendations for Training Future Toxicologic Pathologists Participating in Regulatory-Type, Nonclinical Toxicity Studies
• Successful Drug Development Despite Adverse Preclinical Findings : Part 2 : Examples
• Successful Drug Development Despite Adverse Preclinical Findings : Part 1 : Processes to Address Issues and Most Important Findings
• Global Recognition of Qualified Toxicologic Pathologists : Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies
• Global Recognition of Qualified Toxicologic Pathologists: Credential Review as a Potential Route for Recognizing the Proficiency of Pathologists Involved in Regulatory-type Nonclinical Studies

スポンサーリンク